A new way to treat joint diseases could follow from the first demonstration of using immune cells to produce collagen.
In a promising development for treating joint conditions such as osteoarthritis, researchers have artificially produced human type II collagen, a key component of cartilage, for the first time. They have shown that it can slow the progress of osteoarthritis in rodents and relieve symptoms in people.